Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing [Yahoo! Finance]
Global Ferroptosis Targeting Therapy Market Opportunity Report 2026: Therapeutic Approaches, Technology Development Platforms & Clinical Trials Insights By Company, Country, Indication & Phase [Yahoo! Finance]
PTC Therapeutics to Participate at Upcoming Investor Conferences [Yahoo! Finance]
PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
PTC Therapeutics to Participate at Upcoming Investor Conferences